DIARYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS
申请人:Neuromed Pharmaceuticals, Ltd.
公开号:EP1745042A1
公开(公告)日:2007-01-24
[EN] DIARYLAMINE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS<br/>[FR] DERIVES DE DIARYLAMINE UTILISES COMME BLOQUANTS DES CANAUX CALCIQUES
申请人:NEUROMED TECH INC
公开号:WO2005097779A1
公开(公告)日:2005-10-20
N-diarylaminoalkyl-substituted piperazine/4-aminopiperidine compounds of formula (1) are disclosed, wherein each of A and B is independently a 6-membered aromatic or nonaromatic, carbocyclic or heterocyclic moiety or is an aminoalkyl and wherein one and only one of A and B may be H or alkyl (1-8C) or wherein A and B together form an optionally substituted 6-membered aromatic of nonaromatic, carbocyclic or heterocyclic moiety; R1 is H or alkyl (1-8C), Z is N or CHNR2 wherein R2 is H or alkyl (1-8C), X is straight chain alkylene (1-4C) wherein optionally at least one carbon adjacent to a nitrogen is in the form of C=0; each R3 is an independent substituent; n=0-2; Ar is a six-membered aromatic or heteroaromatic ring; wherein each cyclic moiety included in A or B each Ar moiety in formula (1) may be substituted by one or more substituents. These compounds and salts or conjugated thereof are able to block N-type and T-type calcium channels and are useful for treating conditions mediated by calcium ion channel activity such as chronic pain.
Diarylamine derivatives as calcium channel blockers
申请人:Pajouhesh Hassan
公开号:US20050227999A1
公开(公告)日:2005-10-13
Compounds which are derivatives of diarylamine substituted piperazine and amino-piperidine are useful in treating conditions mediated by calcium ion channel activity.